Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05121038
Title CEND-1 in Combination With Neoadjuvant FOLFIRINOX With or Without Panitumumab (CENDIFOX)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Anup Kasi
Indications

pancreatic ductal adenocarcinoma

appendix adenocarcinoma

colorectal adenocarcinoma

Therapies

CEND-1 + Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin

CEND-1 + Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin + Panitumumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.